New study aims to uncover potential target for preventing blood clots in patients being treated for cancer.
Study Finds New Predictors of Recurring Cancer-Specific Thrombosis
New analysis of the phase III CATCH trial of blood-thinning treatments identifies two clinical indicators for recurrent venous thromboembolism: tumor venous compression and hepatobiliary cancer.
Khorana Score Predicts Cancer Patients’ Thrombosis Risk
The Khorana score, named for its developer, Cleveland Clinic hematologist/oncologist Alok Khorana, MD, effectively forecasts cancer patients’ blood clotting risk based on a collection of simple variables — type of cancer, body mass index and complete blood count.